This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 2 CIPO patents. Top assignee: Boehringer Ingelheim Pharma Kg. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovations of Jacobus Ca Van Meel
Introduction
Jacobus Ca Van Meel is a notable inventor based in Moedling, Austria. He has made significant contributions to the field of pharmacology through his innovative research and development of new compounds. His work focuses on the creation of substituted indolines that exhibit valuable pharmacological properties.
Latest Patents
Jacobus Ca Van Meel holds a patent for "Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs." This invention relates to new substituted indolinones of a general formula, wherein the compounds demonstrate an inhibiting effect on various kinases, viral cyclins, and receptor tyrosine kinases. The compounds are valuable intermediate products for the preparation of these pharmacologically active substances. He has 1 patent to his name.
Career Highlights
Jacobus Ca Van Meel is associated with Boehringer Ingelheim Pharma KG, a leading global pharmaceutical company. His work at the company has allowed him to contribute to the development of innovative therapeutic solutions. His research has the potential to impact various medical fields significantly.
Collaborations
Throughout his career, Jacobus has collaborated with esteemed colleagues, including Rainer Walter and Wolfgang Grell. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Jacobus Ca Van Meel's contributions to the field of pharmacology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical science.